BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20196818)

  • 1. HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients.
    Sayed D; Badr G; Maximous D; Mikhail NN; Abu-Tarboush F; Alhazza IM
    Tissue Antigens; 2010 Jan; 75(1):40-7. PubMed ID: 20196818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer.
    Chen HX; Lin A; Shen CJ; Zhen R; Chen BG; Zhang X; Cao FL; Zhang JG; Yan WH
    Hum Immunol; 2010 Sep; 71(9):892-8. PubMed ID: 20547193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-G is a potential tumor marker in malignant ascites.
    Singer G; Rebmann V; Chen YC; Liu HT; Ali SZ; Reinsberg J; McMaster MT; Pfeiffer K; Chan DW; Wardelmann E; Grosse-Wilde H; Cheng CC; Kurman RJ; Shih IeM
    Clin Cancer Res; 2003 Oct; 9(12):4460-4. PubMed ID: 14555519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro.
    He X; Dong DD; Yie SM; Yang H; Cao M; Ye SR; Li K; Liu J; Chen J
    Ann Surg Oncol; 2010 May; 17(5):1459-69. PubMed ID: 20052552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
    Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
    Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies.
    Paul P; Cabestré FA; Le Gal FA; Khalil-Daher I; Le Danff C; Schmid M; Mercier S; Avril MF; Dausset J; Guillet JG; Carosella ED
    Cancer Res; 1999 Apr; 59(8):1954-60. PubMed ID: 10213506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of HLA-G expression in renal cell carcinoma.
    Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
    Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients.
    Schütt P; Schütt B; Switala M; Bauer S; Stamatis G; Opalka B; Eberhardt W; Schuler M; Horn PA; Rebmann V
    Hum Immunol; 2010 May; 71(5):489-95. PubMed ID: 20156510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients.
    de Kruijf EM; Sajet A; van Nes JG; Natanov R; Putter H; Smit VT; Liefers GJ; van den Elsen PJ; van de Velde CJ; Kuppen PJ
    J Immunol; 2010 Dec; 185(12):7452-9. PubMed ID: 21057081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human leukocyte antigen-G in systemic lupus erythematosus.
    Rosado S; Perez-Chacon G; Mellor-Pita S; Sanchez-Vegazo I; Bellas-Menendez C; Citores MJ; Losada-Fernandez I; Martin-Donaire T; Rebolleda N; Perez-Aciego P
    Hum Immunol; 2008 Jan; 69(1):9-15. PubMed ID: 18295670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
    Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
    Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
    Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
    Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
    Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
    Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
    Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
    J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No expression of human leukocyte antigen G (HLA-G) in colorectal cancer cells.
    Leelawat K; Engprasert S; Pongchai-rerk U; Tuchinda S; Suthipintawong C; Leardkamolkarn V
    J Med Assoc Thai; 2004 Jul; 87(7):816-8. PubMed ID: 15521238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
    Levy EM; Bianchini M; Von Euw EM; Barrio MM; Bravo AI; Furman D; Domenichini E; Macagno C; Pinsky V; Zucchini C; Valvassori L; Mordoh J
    Int J Oncol; 2008 Mar; 32(3):633-41. PubMed ID: 18292941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
    Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
    Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the soluble HLA-G blood serum concentration levels in patients with ovarian cancer and ovarian and deep endometriosis.
    Mach P; Blecharz P; Basta P; Marianowski P; Skret-Magierlo J; Kojs Z; Grabiec M; Wicherek L
    Am J Reprod Immunol; 2010 May; 63(5):387-95. PubMed ID: 20146732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.